These data were generated and previously reported in a brain expression GWAS (eGWAS) by Zou and colleagues23 (link), where the detailed mRNA extraction and quality assessment using RNAqueous kit (Ambion, Grand Island, NY) and RNA 6000 Nano Chip (Agilent, Santa Clara, CA), Whole Genome DASL assay (Illumina, San Diego, CA), and data quality control methods can be found. This eGWAS cohort included 374 cerebellar and 399 temporal cortex mRNA samples from the Mayo Clinic Florida Brain Bank. Neuropathologic diagnoses for the cohort include Alzheimer’s disease, PSP, CBD, Lewy body disease, frontotemporal lobar degeneration, and other diagnoses (Supplementary Table 7). The Bonferroni P-value threshold for SNP/transcript association significance was P < 1.56 × 10−3 (four SNPs and eight probes).